Siry, Deborah
Riffel, Johannes
Salatzki, Janek
André, Florian
Weberling, Lukas Damian
Ochs, Marco
Atia, Noura A.
Hillier, Elizabeth
Albert, David
Katus, Hugo A.
Giannitsis, Evangelos
Frey, Norbert
Friedrich, Matthias G.
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 8 June 2022
Accepted: 19 August 2022
First Online: 5 September 2022
Declarations
:
: The study was approved by the local ethics committee Ethikkommission Medizinische Fakultät Heidelberg with the case number: S-483/2018. All participants provided informed written consent and all methods were performed in accordance with the relevant guidelines and regulations.
: Not applicable.
: MF is advisor, board member and shareholder of Circle Cardiovascular Imaging Inc., Calgary. MF is listed as one of the original patent holders for the United States Patent 15/483,712: MEASURING OXYGENATION CHANGES IN TISSUE AS A MARKER FOR VASCULAR FUNCTION. All other authors do not have any conflicts of interest to declare.